Match!

Identification of Pre-Existing Adaptive Immunity to Cas9 Proteins in Humans

Published on Jan 5, 2018in bioRxiv
· DOI :10.1101/243345
Carsten T. Charlesworth3
Estimated H-index: 3
(Stanford University),
Priyanka S. Deshpande2
Estimated H-index: 2
(Stanford University)
+ 7 AuthorsMatthew H. Porteus49
Estimated H-index: 49
(Stanford University)
Abstract
The CRISPR-Cas9 system has proven to be a powerful tool for genome editing allowing for the precise modification of specific DNA sequences within a cell. Many efforts are currently underway to use the CRISPR-Cas9 system for the therapeutic correction of human genetic diseases. The most widely used homologs of the Cas9 protein are derived from the bacteria Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes). Based on the fact that these two bacterial species cause infections in the human population at high frequencies, we looked for the presence of pre-existing adaptive immune responses to their respective Cas9 homologs, SaCas9 (S. aureus homolog of Cas9) and SpCas9 (S. pyogenes homolog of Cas9). To determine the presence of anti-Cas9 antibodies, we probed for the two homologs using human serum and were able to detect antibodies against both, with 79% of donors staining against SaCas9 and 65% of donors staining against SpCas9. Upon investigating the presence of antigen-specific T-cells against the two homologs in human peripheral blood, we found anti-SaCas9 T-cells in 46% of donors. Upon isolating, expanding, and conducting antigen re-stimulation experiments on several of these donors anti-SaCas9 T-cells, we observed a SaCas9-specific response confirming that these T-cells were antigen-specific. We were unable to detect antigen-specific T-cells against SpCas9, although the sensitivity of the assay precludes us from concluding that such T-cells do not exist. Together, this data demonstrates that there are pre-existing humoral and cell-mediated adaptive immune responses to Cas9 in humans, a factor which must be taken into account as the CRISPR-Cas9 system moves forward into clinical trials.
  • References (36)
  • Citations (74)
📖 Papers frequently viewed together
201241.06Science
6,634 Citations
201341.06Science
11 Authors (Le Cong, ..., Feng Zhang)
8,020 Citations
201341.06Science
5,495 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References36
Newest
#1Justin Eyquem (Kettering University)H-Index: 9
#2Jorge Mansilla-Soto (Kettering University)H-Index: 10
Last. Michel Sadelain (Kettering University)H-Index: 79
view all 9 authors...
Introducing chimeric antigen receptors into the endogenous T-cell receptor locus reduces tonic signalling, averts accelerated T-cell differentiation and delays T-cell exhaustion, leading to enhanced function and anti-tumour efficacy compared to random integrations.
454 CitationsSource
#1Daniel P. Dever (Stanford University)H-Index: 14
#2Rasmus O. Bak (Stanford University)H-Index: 21
Last. Matthew H. PorteusH-Index: 49
view all 16 authors...
These preclinical studies outline a CRISPR-based methodology for correcting β-globin gene mutations in haematopoietic stem cells to advance the development of next-generation therapies for β-haemoglobinopathies.
316 CitationsSource
#1Keiichiro Suzuki (Salk Institute for Biological Studies)H-Index: 41
#2Yuji TsunekawaH-Index: 8
view all 35 authors...
A method for CRISPR-based genome editing that harnesses cellular non-homologous end joining activity to achieve targeted DNA knock-in in non-dividing tissues.
418 CitationsSource
#1Mark A. DeWitt (University of California, Berkeley)H-Index: 11
#2Wendy Magis (Children's Hospital Oakland Research Institute)H-Index: 4
Last. Jacob E. Corn (University of California, Berkeley)H-Index: 34
view all 15 authors...
Sickle cell disease is a genetic disorder caused by a mutation in one of the hemoglobin genes, which causes deformation of red blood cells and results in occlusion of blood vessels, severe pain crises, and progressive organ injury. To correct the mutation that causes this disease, DeWitt et al . modified hematopoietic stem cells from sickle cell disease patients using a CRISPR/Cas9 gene editing approach. The authors showed that the corrected cells successfully engrafted in a mouse model and prod...
197 CitationsSource
#1Wei Leong Chew (Harvard University)H-Index: 8
#2Mohammadsharif Tabebordbar (Harvard University)H-Index: 9
Last. George M. Church (Wyss Institute for Biologically Inspired Engineering)H-Index: 144
view all 9 authors...
Packaging split Cas9 into AAVs increases cargo capacity and allows for efficient genome editing and gene activation in vivo. AAV–split-Cas9 activates the host immune system but does not trigger the extensive cellular damage observed with delivery of Cas9 via DNA electroporation.
221 CitationsSource
#1Hao Yin (MIT: Massachusetts Institute of Technology)H-Index: 29
#2Chun-Qing Song (UMMS: University of Massachusetts Medical School)H-Index: 16
Last. Dana Z. AndersonH-Index: 53
view all 22 authors...
Abstract The combination of Cas9, guide RNA and repair template DNA can induce precise gene editing and the correction of genetic diseases in adult mammals. However, clinical implementation of this technology requires safe and effective delivery of all of these components into the nuclei of the target tissue. Here, we combine lipid nanoparticle-mediated delivery of Cas9 mRNA with adeno-associated viruses encoding a sgRNA and a repair template to induce repair of a disease gene in adult animals. ...
401 CitationsSource
#1Mohammadsharif Tabebordbar (Harvard University)H-Index: 9
#2Kexian Zhu (Harvard University)H-Index: 7
Last. Amy J. Wagers (Harvard University)H-Index: 72
view all 15 authors...
Frame-disrupting mutations in the DMD gene, encoding dystrophin, compromise myofiber integrity and drive muscle deterioration in Duchenne muscular dystrophy (DMD). Removing one or more exons from the mutated transcript can produce an in-frame mRNA and a truncated, but still functional, protein. In this study, we developed and tested a direct gene-editing approach to induce exon deletion and recover dystrophin expression in the mdx mouse model of DMD. Delivery by adeno-associated virus (AAV) of c...
549 CitationsSource
#1Christopher E. Nelson (Duke University)H-Index: 21
#2Chady H. Hakim (MU: University of Missouri)H-Index: 17
Last. Charles A. Gersbach (Duke University)H-Index: 44
view all 14 authors...
Duchenne muscular dystrophy (DMD) is a devastating disease affecting about 1 out of 5000 male births and caused by mutations in the dystrophin gene. Genome editing has the potential to restore expression of a modified dystrophin gene from the native locus to modulate disease progression. In this study, adeno-associated virus was used to deliver the clustered regularly interspaced short palindromic repeats (CRISPR)–Cas9 system to the mdx mouse model of DMD to remove the mutated exon 23 from the d...
606 CitationsSource
INTRODUCTION: Though Staphylococcus aureus is a major pathogen, vaccine trials have failed. In contrast, class-switched antibodies specific to S. aureus are common, implying immune memory formation and suggesting a large pool of S. aureus-reactive helper T-cells. OBJECTIVE: To elucidate the cellular arm of S. aureus-specific immune memory, the T-cell response in humans was characterized. METHODS: The proliferative response of human peripheral blood mononuclear cells (PBMCs) to S. aureus antigens...
53 CitationsSource
#1Rasmus Mortensen (SSI: Statens Serum Institut)H-Index: 7
#2Thomas Nørrelykke Nissen (Copenhagen University Hospital)H-Index: 9
Last. Jes Dietrich (SSI: Statens Serum Institut)H-Index: 35
view all 6 authors...
Each year, millions of people are infected with Streptococcus pyogenes , leading to an estimated 500,000 annual deaths worldwide. For unknown reasons, school-aged children have substantially higher infection rates than adults. The goal for this study was to provide, to our knowledge, the first detailed characterization of the human adaptive immune response against S. pyogenes in both children and adults. We report that all adults in our study, as well as most children, showed immunity against th...
17 CitationsSource
Cited By74
Newest
#1Hongyi Li (Sichuan University)H-Index: 2
#2Yang Yang (Sichuan University)H-Index: 14
Last. Xia Zhao (Sichuan University)H-Index: 46
view all 6 authors...
Based on engineered or bacterial nucleases, the development of genome editing technologies has opened up the possibility of directly targeting and modifying genomic sequences in almost all eukaryotic cells. Genome editing has extended our ability to elucidate the contribution of genetics to disease by promoting the creation of more accurate cellular and animal models of pathological processes and has begun to show extraordinary potential in a variety of fields, ranging from basic research to app...
16 CitationsSource
The ability to edit a specific gene within our genomes using guided-nucleases (Cas9/ZFN/TALEN - CaZiTa) presents huge opportunities for curing many genetic disorders. Delivery of this ‘drug’ within cells is a critical step for such therapies. The ability of recombinant adeno-associated virus (rAAV) to enter cells makes it a perfect choice as a vector for gene therapy. A plasmid comprising the rAAV, the CaZiTa, guide RNAs (for CRISPR) is expected to enter the cell, edit the target gene(s), remain...
Source
#1Safa Tahmasebi (Tehran University of Medical Sciences)H-Index: 3
#2Reza Elahi (Zanjan University of Medical Sciences)H-Index: 2
Last. Abdolreza Esmaeilzadeh (ZNU: University of Zanjan)H-Index: 1
view all 3 authors...
Adoptive cell therapy using CAR T cells has emerged as a novel treatment strategy with promising results against B cell malignancies; however, CAR T cells have not shown much success against solid malignancies. There are several obstacles which diminish the efficacy of CAR T cells, but the immunosuppressive tumor microenvironment (TME) of the tumor stands out as the most important factor. TME includes Tumor-Associated Stroma, Immunosuppressive cells and cytokines, tumor hypoxia and metabolism, a...
11 CitationsSource
#1Robert K. Johnston (SNL: Sandia National Laboratories)H-Index: 1
#2Kyle J. Seamon (SNL: Sandia National Laboratories)H-Index: 8
Last. Jason C. Harper (SNL: Sandia National Laboratories)H-Index: 16
view all 7 authors...
Abstract The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) ribonucleoprotein (RNP) complex is an RNA-guided DNA-nuclease that is part of the bacterial adaptive immune system. CRISPR/Cas9 RNP has been adapted for targeted genome editing within cells and whole organisms with new applications vastly outpacing detection and quantification of gene-editing reagents. Detection of the CRISPR/Cas9 RNP within biological samples is critical for assess...
3 CitationsSource
#1Theano I. Panagopoulou (UCL: University College London)H-Index: 1
#2Qasim A. Rafiq (UCL: University College London)H-Index: 12
Abstract T cells engineered to express a chimeric antigen receptor (CAR) have re-shaped the way hematological malignancies are treated. Despite the overwhelming early clinical success, CAR-T therapies are associated with severe side-effects, disease relapse and often exhibit limited efficacy. In this Review article we summarize the most recent biotechnological advances that have been developed to enhance the efficacy and specificity of CAR-T therapies, as well as to address the key challenges as...
1 CitationsSource
#1Jake L. Weissman (UMD: University of Maryland, College Park)H-Index: 4
#2Rohan M. R. Laljani (UMD: University of Maryland, College Park)H-Index: 1
Last. Philip L. F. Johnson (UMD: University of Maryland, College Park)H-Index: 26
view all 4 authors...
Bacteria and archaea are locked in a near-constant battle with their viral pathogens. Despite previous mechanistic characterization of numerous prokaryotic defense strategies, the underlying ecological drivers of different strategies remain largely unknown and predicting which species will take which strategies remains a challenge. Here, we focus on the CRISPR immune strategy and develop a phylogenetically-corrected machine learning approach to build a predictive model of CRISPR incidence using ...
5 CitationsSource
#1Jacqueline Larouche (UM: University of Michigan)H-Index: 3
#2Carlos A. Aguilar (UM: University of Michigan)H-Index: 13
Cellular identity and state are determined by a collection of molecular components that are specified during development and stabilized thereafter to maintain and protect tissue functions. Alteration of the molecular elements (gene expression program and chromatin state) as a result of disease or age can induce somatic cells to assume different identities or modulate functions. Therapeutic use of this technique, called ‘cellular reprogramming’, is very promising for regenerative medicine, but im...
7 CitationsSource
#1Basudeb Maji (Broad Institute)H-Index: 13
#2Soumyashree A. Gangopadhyay (Broad Institute)H-Index: 6
Last. Amit Choudhary (Broad Institute)H-Index: 15
view all 18 authors...
Summary The precise control of CRISPR-Cas9 activity is required for a number of genome engineering technologies. Here, we report a generalizable platform that provided the first synthetic small-molecule inhibitors of Streptococcus pyogenes Cas9 (SpCas9) that weigh
26 CitationsSource
#1Hao Yin (WHU: Wuhan University)H-Index: 3
#1Hao Yin (WHU: Wuhan University)H-Index: 1
Last. Dana Z. AndersonH-Index: 53
view all 3 authors...
In the past decade, the development of a genome-editing technology mediated by CRISPR has made genetic engineering easier than ever, both in vitro and in vivo. CRISPR systems have enabled important advances in cancer research by accelerating the development of study models or as a tool in genetic screening studies, including those aiming to discover and validate therapeutic targets. In this Review, we discuss these applications as well as new potential uses of CRISPR to assist in cancer detectio...
25 CitationsSource
#1Petros Patsali (The Cyprus Institute of Neurology and Genetics)H-Index: 4
#1Petros Patsali (The Cyprus Institute of Neurology and Genetics)H-Index: 2
Last. Carsten W. Lederer (The Cyprus Institute of Neurology and Genetics)H-Index: 16
view all 3 authors...
Designer nucleases are versatile tools for genome modification and therapy development and have gained widespread accessibility with the advent of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein (Cas) technology. Prokaryotic RNA-guided nucleases of CRISPR/Cas type, since first being adopted as editing tools in eukaryotic cells, have experienced rapid uptake and development. Diverse modes of delivery by viral and non-viral vectors and ongoing discovery...
9 CitationsSource